SENGROVI

Serial Number 79260654
Registration 5934727
700

Registration Progress

Application Filed
May 8, 2019
Under Examination
Approved for Publication
Oct 1, 2019
Published for Opposition
Oct 1, 2019
Registered
Dec 17, 2019

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20191217) (Grace Period Filing)
Due: Jun 17, 2026 Grace Period - 180 days
Original deadline was Dec 17, 2025 (overdue)

Trademark Image

SENGROVI

Basic Information

Serial Number
79260654
Registration Number
5934727
Filing Date
May 8, 2019
Registration Date
December 17, 2019
Published for Opposition
October 1, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 17, 2019
Registration
Registered
Classes
005

Rights Holder

Novo Nordisk Health Care AG

25
Address
The Circle 32/38
CH-8058 Zürich
CH

Ownership History

Novo Nordisk Health Care AG

Original Applicant
25
CH

Novo Nordisk Health Care AG

Owner at Publication
25
CH

Novo Nordisk Health Care AG

Original Registrant
25
CH

Legal Representation

Attorney
Claudia A. Smith

USPTO Deadlines

Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20191217)
Due Date
December 17, 2025
Grace Period Ends
June 17, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Dec 17, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Nov 21, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 6, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Apr 17, 2020 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Mar 28, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 28, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 17, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 17, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 5, 2019 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Oct 1, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 1, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 18, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Sep 18, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Sep 11, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 6, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Aug 29, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 20, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Aug 13, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 13, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 7, 2019 ALIE A ASSIGNED TO LIE Loading...
Jul 31, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 25, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 24, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 15, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 22, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 18, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 13, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of hormonal disorders

Classification

International Classes
005